2-((8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde, Hydrocortisone Impurity, 98%

cas: 14760-49-7 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

2-((8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde, Hydrocortisone Impurity, 98% (CAS 14760-49-7) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 100mg. Oferty producentów: Fluorochem.

• 2D
• 3D

2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde (CAS 14760-49-7) to związek chemiczny o wzorze sumarycznym C21H28O5 i masie molowej 360.4 g/mol. Nazwa systematyczna IUPAC: 2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde. InChIKey: JIELFMXLFHFDRT-VWUMJDOOSA-N.

Dane identyfikacyjne

Wzór sumaryczny	C21H28O5
Masa molowa	360.4 g/mol
Nazwa IUPAC	2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde
InChIKey	JIELFMXLFHFDRT-VWUMJDOOSA-N
SMILES	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)C=O)O)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 21-Dehydrocortisol, (11beta)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-al, Pregn-4-en-21-al, 11,17-dihydroxy-3,20-dioxo-, (11beta)-, Hydrocortisone EP Impurity G, Hydrocortisone 21-Aldehyde Hydrate, 11beta,17-dihydroxy-21-oxoprogesterone, HYDROCORTISONE IMPURITY G [EP IMPURITY], 4-pregnen-11beta,17alpha-diol-3,20-dione-21-al, 11beta,17alpha-dihydroxypregn-4-ene-3,20,21-trione, 11beta,17alpha-dihydroxypregn-4-en-3,20-dione-21-al

Izomery (ten sam wzór sumaryczny)

(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C₂₁H₂₈O₅

(8S,9S,10R,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-17-hydroxy-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione C₂₁H₂₈O₅

(8S,9S,10R,13S,14S,17R)-1,2-dideuterio-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione C₂₁H₂₈O₅

2-hydroxy-2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]acetic acid C₂₁H₂₈O₅

(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione C₂₁H₂₈O₅

(8R,9S,10R,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C₂₁H₂₈O₅

(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C₂₁H₂₈O₅

(1S,2S,10S,11S,14R,15S,17S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-en-5-one C₂₁H₂₈O₅

11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C₂₁H₂₈O₅

1,3-bis[4-(2-methoxyethyl)phenoxy]propan-2-ol C₂₁H₂₈O₅

(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one C₂₁H₂₈O₅

2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetic acid C₂₁H₂₈O₅